Clinical scoring systems, molecular subtypes and baseline [18F]FDG PET/CT image analysis for prognosis of diffuse large B-cell lymphoma
Authors:
Open Access
- 18 December 2024
- journal article
- review article
- Published by Springer Nature in Cancer Imaging
- Vol. 24 (1) , 168
Abstract
Diffuse large B-cell lymphoma (DLBCL) is a highly heterogeneous hematological malignancy resulting in a range of outcomes, and the early prediction of these outcomes has important implications for patient management. Clinical scoring systems provide the most commonly used prognostic evaluation criteria, and the value of genetic testing has also been confirmed by in-depth research on molecular typing. [18F]-fluorodeoxyglucose positron emission tomography / computed tomography ([18F]FDG PET/CT) is an invaluable tool for predicting DLBCL progression. Conventional baseline image-based parameters and machine learning models have been used in prognostic FDG PET/CT studies of DLBCL; however, numerous studies have shown that combinations of baseline clinical scoring systems, molecular subtypes, and parameters and models based on baseline FDG PET/CT image may provide better predictions of patient outcomes and aid clinical decision-making in patients with DLBCL.Keywords
This publication has 106 references indexed in Scilit:
- 2024 Update: Advances in the risk stratification and management of large B‐cell lymphomaAmerican Journal of Hematology, 2023
- [18F]‐FDG PET radiomic model as prognostic biomarker in diffuse large B‐cell lymphomaHematological Oncology, 2023
- Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter studyCancer, 2022
- Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphomaAmerican Journal of Hematology, 2021
- 2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and managementAmerican Journal of Hematology, 2021
- Emerging role of deep learning‐based artificial intelligence in tumor pathologyCancer Communications, 2020
- A better prediction of progression‐free survival in diffuse large B‐cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV maxCancer Medicine, 2019
- Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphomaAmerican Journal of Hematology, 2019
- Double hit and double expressors in lymphoma: Definition and treatmentCancer, 2018
- Simplicity at the cost of predictive accuracy in diffuse large B‐cell lymphoma: a critical assessment of the R‐IPI,IPI, andNCCN‐IPICancer Medicine, 2017